Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
73.99
-0.28 (-0.38%)
At close: Nov 4, 2024, 4:00 PM
15.51
-58.48 (-79.04%)
Pre-market: Nov 5, 2024, 9:04 AM EST
Dr. Reddy's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 299,867 | 279,164 | 245,879 | 214,391 | 189,722 | 174,600 | Upgrade
|
| Revenue Growth (YoY) | 12.37% | 13.54% | 14.69% | 13.00% | 8.66% | 13.49% | Upgrade
|
| Cost of Revenue | 122,068 | 115,557 | 106,536 | 100,551 | 86,645 | 80,591 | Upgrade
|
| Gross Profit | 177,799 | 163,607 | 139,343 | 113,840 | 103,077 | 94,009 | Upgrade
|
| Selling, General & Admin | 86,402 | 77,201 | 68,026 | 62,081 | 54,650 | 50,129 | Upgrade
|
| Research & Development | 25,906 | 22,873 | 19,381 | 17,482 | 16,541 | 15,410 | Upgrade
|
| Other Operating Expenses | -653 | -1,775 | -1,480 | -1,642 | -1,024 | -843 | Upgrade
|
| Operating Expenses | 111,655 | 98,299 | 85,927 | 77,921 | 70,167 | 64,696 | Upgrade
|
| Operating Income | 66,144 | 65,308 | 53,416 | 35,919 | 32,910 | 29,313 | Upgrade
|
| Interest Expense | -2,342 | -1,711 | -1,428 | -958 | -970 | -983 | Upgrade
|
| Interest & Investment Income | 2,278 | 2,278 | 1,180 | 965 | 826 | 888 | Upgrade
|
| Earnings From Equity Investments | 182 | 147 | 370 | 703 | 480 | 561 | Upgrade
|
| Currency Exchange Gain (Loss) | 278 | 278 | 2,225 | 1,835 | 1,240 | 639 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,060 | 46 | -152 | 277 | 557 | 5 | Upgrade
|
| EBT Excluding Unusual Items | 67,600 | 66,346 | 55,611 | 38,741 | 35,043 | 30,423 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3,103 | 3,103 | 1,028 | - | - | 929 | Upgrade
|
| Gain (Loss) on Sale of Assets | 900 | 900 | -1,211 | 1,119 | -42 | -10 | Upgrade
|
| Asset Writedown | -866 | -3 | -699 | -7,562 | -8,588 | -16,767 | Upgrade
|
| Legal Settlements | 1,524 | 1,524 | 5,638 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 3,457 | Upgrade
|
| Pretax Income | 72,261 | 71,870 | 60,367 | 32,298 | 26,413 | 18,032 | Upgrade
|
| Income Tax Expense | 18,067 | 16,186 | 15,300 | 8,730 | 9,175 | -1,466 | Upgrade
|
| Earnings From Continuing Operations | 54,194 | 55,684 | 45,067 | 23,568 | 17,238 | 19,498 | Upgrade
|
| Minority Interest in Earnings | -862 | - | - | - | - | - | Upgrade
|
| Net Income | 53,332 | 55,684 | 45,067 | 23,568 | 17,238 | 19,498 | Upgrade
|
| Net Income to Common | 53,332 | 55,684 | 45,067 | 23,568 | 17,238 | 19,498 | Upgrade
|
| Net Income Growth | 4.80% | 23.56% | 91.22% | 36.72% | -11.59% | 3.74% | Upgrade
|
| Shares Outstanding (Basic) | 833 | 832 | 830 | 829 | 829 | 829 | Upgrade
|
| Shares Outstanding (Diluted) | 834 | 834 | 832 | 832 | 832 | 830 | Upgrade
|
| Shares Change (YoY) | 0.17% | 0.19% | 0.03% | 0.01% | 0.14% | -0.07% | Upgrade
|
| EPS (Basic) | 64.04 | 66.93 | 54.29 | 28.42 | 20.79 | 23.53 | Upgrade
|
| EPS (Diluted) | 63.95 | 66.80 | 54.17 | 28.34 | 20.73 | 23.48 | Upgrade
|
| EPS Growth | 4.63% | 23.32% | 91.16% | 36.70% | -11.71% | 3.81% | Upgrade
|
| Free Cash Flow | 12,343 | 29,030 | 47,552 | 13,448 | 25,962 | 24,995 | Upgrade
|
| Free Cash Flow Per Share | 14.80 | 34.83 | 57.16 | 16.17 | 31.22 | 30.10 | Upgrade
|
| Dividend Per Share | - | 8.000 | 8.000 | 6.000 | 5.000 | 5.000 | Upgrade
|
| Dividend Growth | - | 0% | 33.33% | 20.00% | 0% | 25.00% | Upgrade
|
| Gross Margin | 59.29% | 58.61% | 56.67% | 53.10% | 54.33% | 53.84% | Upgrade
|
| Operating Margin | 22.06% | 23.39% | 21.72% | 16.75% | 17.35% | 16.79% | Upgrade
|
| Profit Margin | 17.79% | 19.95% | 18.33% | 10.99% | 9.09% | 11.17% | Upgrade
|
| Free Cash Flow Margin | 4.12% | 10.40% | 19.34% | 6.27% | 13.68% | 14.32% | Upgrade
|
| EBITDA | 80,269 | 79,006 | 65,173 | 47,743 | 45,706 | 41,785 | Upgrade
|
| EBITDA Margin | 26.77% | 28.30% | 26.51% | 22.27% | 24.09% | 23.93% | Upgrade
|
| D&A For EBITDA | 14,125 | 13,698 | 11,757 | 11,824 | 12,796 | 12,472 | Upgrade
|
| EBIT | 66,144 | 65,308 | 53,416 | 35,919 | 32,910 | 29,313 | Upgrade
|
| EBIT Margin | 22.06% | 23.39% | 21.72% | 16.75% | 17.35% | 16.79% | Upgrade
|
| Effective Tax Rate | 25.00% | 22.52% | 25.34% | 27.03% | 34.74% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.